日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A MET-Targeted Variable New Antigen Receptor (VNAR) Theranostic for Non-Small Cell Lung Cancer.

针对MET的可变新抗原受体(VNAR)治疗诊断技术用于非小细胞肺癌。

Minne Rachel L, West Jayden L, Luo Natalie Y, Nickel Kwangok P, Gunaratne Gihan S, Ott Kendahl L, Gallant Joseph P, Barrett Kendall E, Mork Caroline M, Javeri Saahil, Wopat Madalynn R, Lopez Loren D Rivera, Toscano Will A, Zitzer Nina C, Kwon Ohyun, Teague Jordan, Bunker Brittany, Phillips Jessica M, Idrissou Malick Bio, Rojas Hansel Comas, Mixdorf Jason C, Aluicio-Sarduy Eduardo, Engle Jonathan W, Bednarz Bryan, Hernandez Reinier, Kimple Randall J, Baschnagel Andrew M, LeBeau Aaron M

MET Inhibitor Capmatinib Radiosensitizes MET Exon 14-Mutated and MET-Amplified Non-Small Cell Lung Cancer

MET抑制剂卡马替尼可增强MET 14号外显子突变和MET扩增的非小细胞肺癌的放射敏感性

Ramesh, Shrey; Cifci, Ahmet; Javeri, Saahil; Minne, Rachel L; Longhurst, Colin A; Nickel, Kwangok P; Kimple, Randall J; Baschnagel, Andrew M

Development of an Engineered Single-Domain Antibody for Targeting MET in Non-Small Cell Lung Cancer.

开发一种靶向非小细胞肺癌MET的工程化单域抗体

Luo Natalie Y, Minne Rachel L, Gallant Joseph P, Gunaratne Gihan S, West Jayden L, Javeri Saahil, Robertson Austin J, Lake Eric W, Engle Jonathan W, Mixdorf Jason C, Aluicio-Sarduy Eduardo, Nickel Kwang P, Hernandez Reinier, Kimple Randall J, Baschnagel Andrew M, LeBeau Aaron M

Genomic and Immune Landscape Comparison of MET Exon 14 Skipping and MET-Amplified Non-small Cell Lung Cancer

MET 14号外显子跳跃突变与MET扩增型非小细胞肺癌的基因组和免疫图谱比较

Minne, Rachel L; Luo, Natalie Y; Traynor, Anne M; Huang, Minxuan; DeTullio, Luisina; Godden, Jen; Stoppler, Melissa; Kimple, Randall J; Baschnagel, Andrew M